These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15359289

  • 1. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
    Noblitt LW, Bangari DS, Shukla S, Knapp DW, Mohammed S, Kinch MS, Mittal SK.
    Cancer Gene Ther; 2004 Nov; 11(11):757-66. PubMed ID: 15359289
    [Abstract] [Full Text] [Related]

  • 2. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy.
    Noblitt LW, Bangari DS, Shukla S, Mohammed S, Mittal SK.
    Cancer Gene Ther; 2005 Jan; 12(1):46-53. PubMed ID: 15486559
    [Abstract] [Full Text] [Related]

  • 3. Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
    Carles-Kinch K, Kilpatrick KE, Stewart JC, Kinch MS.
    Cancer Res; 2002 May 15; 62(10):2840-7. PubMed ID: 12019162
    [Abstract] [Full Text] [Related]

  • 4. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
    Nasreen N, Mohammed KA, Lai Y, Antony VB.
    Cancer Lett; 2007 Dec 18; 258(2):215-22. PubMed ID: 17949899
    [Abstract] [Full Text] [Related]

  • 5. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
    Wykosky J, Gibo DM, Stanton C, Debinski W.
    Mol Cancer Res; 2005 Oct 18; 3(10):541-51. PubMed ID: 16254188
    [Abstract] [Full Text] [Related]

  • 6. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
    Tandon M, Vemula SV, Sharma A, Ahi YS, Mittal S, Bangari DS, Mittal SK.
    J Gene Med; 2012 Feb 18; 14(2):77-89. PubMed ID: 22228563
    [Abstract] [Full Text] [Related]

  • 7. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
    Larsen AB, Stockhausen MT, Poulsen HS.
    Cell Signal; 2010 Apr 18; 22(4):636-44. PubMed ID: 19948216
    [Abstract] [Full Text] [Related]

  • 8. Differential EphA2 epitope display on normal versus malignant cells.
    Coffman KT, Hu M, Carles-Kinch K, Tice D, Donacki N, Munyon K, Kifle G, Woods R, Langermann S, Kiener PA, Kinch MS.
    Cancer Res; 2003 Nov 15; 63(22):7907-12. PubMed ID: 14633720
    [Abstract] [Full Text] [Related]

  • 9. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H, Miao H, Gerber L, Singh J, Denning MF, Gilliam AC, Wang B.
    Cancer Res; 2006 Jul 15; 66(14):7050-8. PubMed ID: 16849550
    [Abstract] [Full Text] [Related]

  • 10. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
    Abraham S, Knapp DW, Cheng L, Snyder PW, Mittal SK, Bangari DS, Kinch M, Wu L, Dhariwal J, Mohammed SI.
    Clin Cancer Res; 2006 Jan 15; 12(2):353-60. PubMed ID: 16428472
    [Abstract] [Full Text] [Related]

  • 11. Ligand binding up-regulates EphA2 messenger RNA through the mitogen-activated protein/extracellular signal-regulated kinase pathway.
    Pratt RL, Kinch MS.
    Mol Cancer Res; 2003 Dec 15; 1(14):1070-6. PubMed ID: 14707290
    [Abstract] [Full Text] [Related]

  • 12. A conditional feedback loop regulates Ras activity through EphA2.
    Macrae M, Neve RM, Rodriguez-Viciana P, Haqq C, Yeh J, Chen C, Gray JW, McCormick F.
    Cancer Cell; 2005 Aug 15; 8(2):111-8. PubMed ID: 16098464
    [Abstract] [Full Text] [Related]

  • 13. EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
    Zelinski DP, Zantek ND, Stewart JC, Irizarry AR, Kinch MS.
    Cancer Res; 2001 Mar 01; 61(5):2301-6. PubMed ID: 11280802
    [Abstract] [Full Text] [Related]

  • 14. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
    Kong H, Huang ZH, Li Q, Yang LC, Yu JL, Li Z.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun 01; 28(6):907-10. PubMed ID: 18583225
    [Abstract] [Full Text] [Related]

  • 15. [Expression of EphA2 and EphrinA1 in human renal cell carcinoma and its relationship with angiogenesis].
    Xu JS, Zhang JX, Geng TH, Wang YF, Wang XL, Zuo LF.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun 01; 31(6):438-41. PubMed ID: 19950554
    [Abstract] [Full Text] [Related]

  • 16. EphA2/ephrinA1 mRNA expression and protein production in adenoid cystic carcinoma of salivary gland.
    Shao Z, Zhu F, Song K, Zhang H, Liu K, Shang Z.
    J Oral Maxillofac Surg; 2013 May 01; 71(5):869-78. PubMed ID: 23298804
    [Abstract] [Full Text] [Related]

  • 17. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.
    Fang WB, Brantley-Sieders DM, Parker MA, Reith AD, Chen J.
    Oncogene; 2005 Nov 24; 24(53):7859-68. PubMed ID: 16103880
    [Abstract] [Full Text] [Related]

  • 18. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application.
    Fox BP, Kandpal RP.
    Biochem Biophys Res Commun; 2004 Jun 11; 318(4):882-92. PubMed ID: 15147954
    [Abstract] [Full Text] [Related]

  • 19. A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells.
    Wykosky J, Gibo DM, Debinski W.
    Mol Cancer Ther; 2007 Dec 11; 6(12 Pt 1):3208-18. PubMed ID: 18089715
    [Abstract] [Full Text] [Related]

  • 20. Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct.
    Hammond SA, Lutterbuese R, Roff S, Lutterbuese P, Schlereth B, Bruckheimer E, Kinch MS, Coats S, Baeuerle PA, Kufer P, Kiener PA.
    Cancer Res; 2007 Apr 15; 67(8):3927-35. PubMed ID: 17440108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.